Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

NCT05626504 is registered in ClinicalTrials.gov with King's College Hospital NHS Trust as lead sponsor.

NCT NCT05626504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05626504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
Lead sponsor
King's College Hospital NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
October 27, 2022
Completion date
March 31, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain aneurysm, intracranial hemorrhages, stroke